ArticleHaematologica2025

Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.

Roberta Soscia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.